We evaluated the efficacy of the titanium vocal fold medializing implant (TVFMI) for the treatment of unilateral vocal fold paralysis (UVFP) on the basis of acoustic, aerodynamic, and mucosal wave measurements in an excised larynx setup.
INTRODUCTION
Unilateral vocal fold paralysis (UVFP) is typically caused by injury to the recurrent laryngeal nerve, which controls the intrinsic laryngeal muscles necessary for vocal fold adduction. The inability to adduct the paralyzed vocal fold impairs voice, swallowing, and breathing functions. 1 Current treatment of glottic insufficiency due to UVFP is primarily surgical, with the goal of medializing the paralyzed vocal fold to improve laryngeal function. Various autogenous and alloplastic materials have been utilized to adduct the paralyzed vocal fold and improve the associated dysphonia. 2, 3 Vocal fold injections can be used to achieve medialization of the vocal folds by increasing their volume and stiffness. Although this treatment can be effective in the partial restoration of vocal fold function, the resultant vocal fold stiffness decreases or eliminates the mucosal wave. 2, 4 Overcorrection of the vocal fold is difficult to reverse and negatively alters the vocal fold configuration at the anterior commissure, leading to abnormal acoustic and aerodynamic parameters of phonation. 5 Additionally, the fact that injected materials are reabsorbed by the surrounding tissue over time may decrease or negate the initial improvements in laryngeal function following surgery. 6 Since its introduction by Isshiki et al, 3, 7 thyroplasty has become an increasingly popular method for correcting UVFP. This method entails medializing the vocal fold with an implant -commonly a silicone wedge -inserted through a window in the thyroid cartilage. 3, 7 The Isshiki thyroplasty has been found to improve vocal quality. 8, 9 Insertion of the implant is performed under local anesthesia, which provides the ability to adjust the degree of medialization on the basis of intraoperative phonation. 10 Thyroplasty also offers advantages over injection laryngoplasty. With an implant, the membranous vocal fold structure is preserved, and the procedure is reversible. 11 Injected material also tends to migrate through the laryngeal tissue over time, whereas solid implants maintain a stable shape and size. 12 Despite its benefits, thyroplasty with a silicone implant presents several disadvantages in both technique and implant material. The silicone implant must be carved during surgery, prolonging the operation time and decreasing standardization of the procedure. Suboptimal shaping can hinder improvement of breathing, swallowing, and voicing functions. 10, 13, 14 After the procedure, allergic reactions to silicone have also been observed. 15 Submucosal hemorrhage and extrusion of the implant, causing obstruction of the laryngeal system, are also possible complications. 16 In response to the complications encountered in thyroplasty using a silicone implant, alternative implant materials have been proposed. These alternatives have included implants made of ceramic, 17 Gore-Tex, 18 and hydroxyapatite. 13 The concept of an adjustable implant has received attention recently, because endolaryngeal swelling and hematoma can affect the intraoperative evaluation of phonation in determining the degree of medialization. Adjustable implant systems, such as that developed by Montgomery and Montgomery, 14 have attempted to standardize the shape and size of laryngeal implants to reduce the trauma and time required for surgery. These implants also allow for postoperative adjustment without replacing the implant. 14, 19 However, these adjustable implants had the disadvantages of complicated designs and discrete degrees of medialization. Previous adjustable implants were composed of multiple parts, and variation of medialization required manipulation of a monometric screw or the insertion of different-sized preformed implants.
The titanium vocal fold medializing implant (TVFMI) was developed by Friedrich 20 to address concerns regarding current thyroplasty techniques. The results of initial clinical trials indicated that the implant succeeded in significantly reducing the width of the glottal gap and had several advantages over previous methods of vocal fold medialization. 20 Using a preformed implant decreased operation time, which resulted in reduced intralaryngeal swelling and hematoma during and after surgery. The TVFMI is also unlikely to migrate through laryngeal tissue, because it is compressed during insertion but expands to its original conformation in the laryngeal tissue, creating a secure fit with the thyroid window. Anchoring the implant with sutures to the thyroid lamina provides fixation and stabilization, further reducing the risk of extrusion. In a clinical study of 20 patients, no extrusion was observed 2, 6, or 12 months after the procedure. This system standardized the implant shape and size, and the use of titanium provided the malleability necessary to adapt the implant to individual patients. In contrast to earlier adjustable implant models, the TVFMI provides adjustability in medialization along a continuous scale by pressing the posterior part of the implant inward and securing its dorsal flange to the thyroid cartilage to maintain that depth. The simplicity of the TVFMI allows for its adaptability by use of standard otolaryngology equipment, similar to earlier thyroplasty methods, without the complication of forming an implant during surgery.
Additional studies have evaluated the effect of medialization thyroplasty using the TVFMI in patients with UVFP. Videostroboscopy indicated almost complete glottal closure after thyroplasty in most patients. 21 Subjective evaluations of laryngeal function by patients indicated significant improvements in voice quality and vocal efficiency, as well as reduced hoarseness. There were also significant improvements in nonphonatory activities such as increased breathing control, reduced dyspnea during phonation, and recovered laughing and coughing capabilities. Acoustic analysis indicated significant decreases in jitter, shimmer, irregularity, and noise in the voice signal, as well as significant increases in its period correlation and glottal-to-noise excitation ratio. 21, 22 Additionally, the TVFMI achieved vocal fold medialization without compromising respiratory performance. This advantage was determined by observing the effect of medialization using the implant on pulmonary function during physical exertion. 23 Although previous studies have examined the effects of the TVFMI on pulmonary function, its effects on aerodynamic parameters of phonation have not been examined.
The effect of TVFMI insertion on the mucosal wave has not been analyzed in patients or excised larynx models. Although thyroplasty has been used as a technique for more than 20 years, the postmedialization mucosal wave has only been analyzed with stroboscopy and glottography. 19, [24] [25] [26] [27] Videostroboscopy is unable to accurately image irregular patterns of vibration characterized by aperiodicity or changes in fundamental frequency, because it creates a composite image of the mucosal wave averaged over several cycles. 28 High-speed video is an improved method of mucosal wave analysis, because it allows for real-time visualization of the mucosal wave. 29 In a comparison of the accuracy of the two methods in characterizing the mucosal wave in pathological larynges, high-speed video was found to be significantly more accurate and interpretable than stroboscopy. [29] [30] [31] These attributes allow for quantification of the impact of the TVFMI on vibration.
In this study, an excised larynx model was used to examine the effects of the TVFMI on the aerody- namic parameters of phonation threshold flow, phonation threshold pressure, and phonation threshold power; the acoustic parameters of jitter, shimmer, and signal-to-noise ratio; and the mucosal wave parameters of amplitude and phase difference. Previous studies have used excised canine larynges as a model for UVFP. Noordzij et al [32] [33] [34] performed a series of studies evaluating arytenoid adduction and type I thyroplasty in a canine model. Additionally, the canine model was recently used to model unilateral vocal fold paralysis by Czerwonka et al. 35 Taking measurements of these parameters in a controlled environment eliminates the potential human variability that may be present in clinical studies.
MATERIALS AND METHODS
Larynges. Eight larynges were harvested postmortem from dogs sacrificed for nonresearch purposes. The larynges were excised according to the protocol described by Jiang and Titze. 36 After excision, the larynges were examined for evidence of trauma or disorders and frozen in 0.9% saline solution.
Apparatus. Immediately before the experiment, the epiglottis, corniculate cartilages, cuneiform cartilages, and ventricular folds of each larynx were dissected away to expose the true vocal folds. The superior cornu and the posterosuperior part of the thyroid cartilage ipsilateral to the normal vocal fold were also dissected away to facilitate insertion of lateral micrometers into the arytenoid cartilage. The larynx was mounted on the apparatus (Fig 1) as specified by Jiang and Titze. 36 The trachea was fastened by a metal pull clamp to a tube connected to the pseudolung of the apparatus. Through the insertion of one 3-pronged micrometer in the arytenoid cartilage ipsilateral to the dissected thyroid cartilage (Fig 2A) , only one vocal fold was adducted, simulating UVFP with the unadducted vocal fold, as done by Czerwonka et al. 35 The level of the adducted vocal fold was adjusted before the first trial by moving the micrometer in the superior and inferior directions until it was in the same plane as the unadducted vocal fold. The superior portion of the thyroid cartilage midline was sutured to a third micrometer, allowing for precise control of vocal fold elongation. We kept vocal fold adduction, height, and elongation constant by maintaining the same micrometer positions throughout trials.
The apparatus used to initiate and sustain phonation in these trials was designed to simulate the human respiratory system. Pressurized airflow was passed through 2 Concha Therm III humidifiers (Fisher & Paykel Healthcare Inc, Laguna Hills, California) in series to humidify and warm the air. The occurrence of dehydration was further diminished by frequent application of 0.9% saline solution between trials. Airflow was controlled manually throughout the experiment and was measured by an Omega airflow meter (model FMA-1601A, Omega Engineering Inc, Stamford, Connecticut). Pressure measurements were taken immediately before the air passed into the larynx, by means of a Heise digital pressure meter (901 series, Ashcroft Inc, Stratford, Connecticut).
Acoustic data were collected with a Sony microphone (model ECM-88, Sony Electronics Inc, New York, New York). The microphone was positioned at a 45° angle to the vertical axis of the vocal tract and approximately 10 cm from the glottis to minimize acoustic noise produced by turbulent airflow. The acoustic signal was subsequently amplified by a Symetrix preamplifier (model 302, Symetrix Inc, Mountlake Terrace, Washington). A National Instruments data acquisition board (model AT-MIO-16, National Instruments Corp, Austin, Texas) and customized LabVIEW 8.5 software were used to simultaneously record airflow, pressure, and acoustic data on a personal computer. The aerodynamic data were recorded at a sampling rate of 200 Hz, and the acoustic data were recorded at a sampling rate of 40,000 Hz. Experimental trials were conducted in a triple-walled, soundproof room to reduce background noise and stabilize humidity levels and temperature.
The vocal fold mucosal wave was recorded for approximately 200 ms during phonation by a highspeed digital camera (model Fastcam-ultima APX; Photron, San Diego, California). High-speed video recordings of the movement were made with a resolution of 512 × 256 pixels at a rate of 4,000 Hz.
Experimental Methods. The trials were conducted as a sequence of 5-second periods of phonation, followed by 5-second periods of rest. The sequence of phonating and resting periods was repeated on the same larynx in succession for a total of 10 cycles. During each period of phonation, the airflow passing through the laryngeal system was manually increased gradually and consistently until the onset of phonation.
The TVFMI (Heinz Kurz Company, Dusslingen, Germany) was inserted into the larynx through a thyroplasty window in the thyroid cartilage ipsilateral to the paralyzed vocal fold, according to the protocol described by Friedrich. 20 Optimal medialization was determined empirically by minimizing the aerodynamic power necessary to initiate phonation. This position was stabilized with sutures to the thyroid cartilage. The implant is available in 3 sizes, and different dimension thyroplasty windows are required for the insertion of each. In this study, the 13mm implant was used in all larynges, requiring a 6 × 11-mm window.
Data Analysis. Phonation was evaluated before and after insertion of the implant. The measured values of airflow and pressure that coincided with the initiation of phonation were recorded as the onset phonation threshold flow and the onset phonation threshold pressure, respectively. The phonation threshold power was calculated as the product of these values.
Phonation threshold flow, pressure, and power were determined manually with a custom LabView 8.5 program. The program graphically displayed the spectrogram, airflow, and pressure signals as functions of time for each trial; airflow and pressure values corresponding to the initiation of phonation were recorded as phonation threshold flow and phonation threshold pressure, respectively. The coefficients of the wave function for this curve were used to derive the frequency, amplitude, and phase of the mucosal wave of each vocal fold lip, both before and after implant insertion. The intervocal fold phase difference was calculated as the absolute value of the divergence between the sinusoidal phase measurements for the right and left upper folds. The mucosal wave amplitude was calculated as the average of the amplitudes of the upper and lower paralyzed vocal fold lips. With the available technology, only relative values, rather than absolute values, could be obtained. The relative values were sufficient for pretreatment-posttreatment comparisons. Changes in glottal gap were evaluated by measuring the relative change after medialization.
Paired t-tests were used to determine whether inserting the implant had a significant effect on the measured parameters. If the data were not normal, a Mann-Whitney rank sum test was performed. The tests were 2-tailed, and a significance (α) level of 0.05 was used. Table. Paired t-tests demonstrated that there were significant decreases in the phonation threshold flow and phonation threshold power after medialization. The phonation threshold flow decreased from 127 mL/s to 46 mL/s (p < 0.001), and the phonation threshold power decreased from 2,301 mL/s*cm H2O to 649 mL/s*cm H2O (p = 0.008; Fig 3A) . The phonation threshold pressure decreased from 16.41 cm H2O to 12.48 cm H2O after medialization, but this difference was not significant (p = 0.081).
RESULTS

Summary data can be seen in the
The signal-to-noise ratio, jitter, and shimmer data before and after TVFMI insertion are provided in Fig 3B- D. There were significant changes in each of these parameters after medialization. The mean signal-to-noise ratio increased from 2.43 to 6.65 (p = 0.05). The mean jitter decreased from 7.15% to 3.58% (p = 0.005), and the mean shimmer decreased from 27.80% to 13.69% (p = 0.034).
There was also a significant decrease in the glottal gap. The glottal gap decreased from 68.98 to 30.75 (p = 0.004; Fig 3E) . Although changes in the phase difference and amplitude of the mucosal wave were discernible, they were not significant. The mean phase difference between the normal and paralyzed vocal folds decreased from 1.03 to 0.008 (p = 0.15). The mean amplitude of the paralyzed vocal fold decreased from 1.71 to 1.64 (p = 0.78).
DISCUSSION
This study provides an objective evaluation of the effect of TVFMI insertion on the aerodynamic, acoustic, and mucosal wave characteristics of phonation. By simulating UVFP in an excised larynx model, we made these measurements in a controlled and repeatable environment. The results supplement those of previous studies that have examined the effect of the implant on pulmonary aerodynamic and acoustic characteristics of phonation and provide support for its therapeutic use in the treatment of UVFP.
Inserting the TVFMI decreased the aerodynamic power necessary to produce phonation. This decrease was caused by medialization of the paralyzed vocal fold, as demonstrated by a significant reduction in glottal gap. The decrease in phonation threshold flow was significant, whereas the decrease in phonation threshold pressure was not. This difference may exist because phonation threshold flow is more sensitive than phonation threshold pressure to changes in glottal abduction, as demonstrated in an excised larynx experiment by Hottinger et al. 37 This decrease in the airflow required to initiate phonation also increases the acoustic quality of the voice signal. The signal-to-noise ratio increased because signal power in the form of phonation increased while noise power in the form of airflow decreased. Additionally, decreases in the perturbation measures of jitter and shimmer were also observed and can be attributed to the vocal fold medialization's restoring vocal fold contact and vibrational periodicity.
There were discernible changes in the mucosal wave characteristics after TVFMI insertion, although these differences were not statistically significant. Thyroplasty type I increases the closed phase over 1 cycle, producing an improvement in glottic vibration, which has been correlated with more efficient phonation. 38 In addition, the phase difference between the right and left vocal folds decreased from 1.03 to 0.008, reflective of improved vocal fold symmetry. Phase difference is typically an intra-vocal fold parameter equal to the difference between the phases of the upper and lower regions of the same vocal fold. The lack of significance in this decrease may have resulted from an insufficient sample size. It could also be due to inadequate color contrast in some of the video recordings. Analysis is dependent on threshold-based edge detection and the subsequent fitting of a sinusoidal curve to the mucosal wave. Threshold-based edge detection requires color contrast between the vocal fold tissue and the glottal Measurements made before and after TVFMI insertion. A) Phonation threshold power significantly decreased, from 1,987 cm H2O*mL/s to 503 cm H2O*mL/s (p = 0.008). B) Signal-to-noise ratio significantly increased, from 1.96 to 6.36 (p = 0.05). C) Jitter significantly decreased, from 7.15% to 3.58% (p = 0.005). D) Shimmer significantly decreased, from 27.80% to 13.69% (p = 0.034). E) Glottal gap width significantly decreased, from 68.98 to 30.75 (p = 0.004).
gap. Although mucosal wave movement was still discernible on the paralyzed vocal fold after TVFMI insertion, the adduction of the vocal fold by the implant made this contrast difficult to distinguish.
Hyperadduction of the vocal fold would result in increased jitter and shimmer; the results of this study indicate that hyperadduction did not occur, as jitter and shimmer were both significantly decreased. Hyperadduction would also lead to pressed phonation due to complete closure of the glottic gap; however, the glottal gap was significantly decreased but not eliminated.
Although the TVFMI is a patented implant for clinical use, the measurement of acoustic, aerodynamic, and mucosal wave parameters in a controlled setting provides additional support for its use. Physicians in different regions have personal preferences for the numerous materials used in thyroplasty; standardized measurements of the effects of different implants provide a quantitative basis for their comparison. The TVFMI is not yet widely used in the United States, so additional information on its effectiveness in treating UVFP may benefit clinicians. This study further contributes to the body of scientific research because it examined the effects of medialization using TVFMI on physiological parameters, including the novel parameters of phonatory aerodynamics and high-speed video analysis of the mucosal wave.
The results of this study provide objective support for the TVFMI that supplements previous hu-man subject studies. [21] [22] [23] By examining the effect of the procedure on a comprehensive range of phonatory parameters in a controlled experimental setting, we reduced variation in these parameters that was unrelated to TVFMI insertion. Although Schneider et al 22, 23 determined that TVFMI insertion did not affect aerodynamic parameters relating to pulmonary function during physical exertion, the effect of this procedure on vocal aerodynamics has not been previously studied.
Future research could use the excised larynx model to compare TVFMI insertion to injection or thyroplasty using other materials such as silicone or hydroxyapatite. This would allow for objective assessment and direct quantitative comparisons between different treatments for UVFP. This is the first study evaluating the effect of TVFMI insertion on vocal aerodynamics and mucosal wave characteristics. Future studies could mea sure these parameters in human subjects with the aim of quantitatively determining the optimal im plant position.
CONCLUSIONS
The TVFMI was effective in achieving vocal fold medialization, significantly improving vocal aerodynamic and acoustic characteristics of phonation and discernibly improving mucosal wave characteristics. This study provides objective, quantitative support for the use of the TVFMI in improving vocal function in patients with UVFP.
